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On the Relevance of the “Genetics-Based” Approach to   
Medicine for Sociological Perspectives on Medical Specialization 
Abstract: This paper draws on a study on the development of medical genetics as a medical 
specialism in the UK and Canada to reflect on how local and national contexts affect specialty 
formation. The paper begins by supporting earlier findings in the literature that stress, first, 
technological innovations as driving specialty formation, and, second, the domination of 
physicians in the division of medical labour. Beyond this, however, the paper explores the 
specific circumstances under which geneticists set about turning their work into a medical 
specialism based on a “genetics-based approach” to illness and how “medical genetics” as a 
specialism was assessed and configured to fit national and regional health service requirements. 
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In this paper, I draw on a work-in-progress summary of a cross-national study I am completing 
on the development and growth of medical genetics as a specialism in the UK and Canada to 
explore the circumstances under which the geneticists involved set about turning their work into 
a medical specialism based on a “genetics-based approach” to illness and how medical genetics 
as a service specialism was assessed and configured to fit national and regional health service 
requirements.1 I have elsewhere (2001:457-65) provided a detailed survey of the relevant 
materials in the sociology of professions literature for studying national patterns of specialization 
in medicine and noted that at least four discrete lines of empirical research can be discerned, each 
one implicitly or explicitly representing a distinct way of understanding the specialization 
process and the collective character of the medical profession.  
The first line of inquiry, building on earlier research that predicted incessant 
professionalization of occupations, stressed unfolding internal differentiation within professional 
organizations and the need to manage divergent beliefs, values and interests (e.g., Hughes, 1958, 
1971; Janowitz, 1960; Glaser, 1964; Bucher and Stelling, 1964). A number of these writers 
indicated that increasing bureaucratization was limiting or reducing the range of activities and/or 
discretion of professionals (e.g., Wilensky, 1964; Hall, 1968; Johnson, 1972; Haug, 1973; Ritzer 
and Walczak, 1988).  This was followed by a second line of inquiry, the so-called “power 
dominance perspective” on collective autonomy and professional control. With specific regard to 
medicine, Eliot Freidson (1970) argued that the organized autonomy of physicians had broadened 
into dominance over kindred occupations. Magali Sarfatti Larson (1977) emphasized the 
movement to standardization of practices and control over the dissemination of the knowledge 
base to dominate the market in knowledge-based services. Similarly, Andrew Abbott’s “system 
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of professions” (1988) put the accent on “cultural work” that would ensure that clients, 
competitors, the state and the public acknowledge the value of expertise and service offered by 
professionals. Relatedly, a third line of inquiry underscored mechanisms of social control and the 
dominance of medicine was said to have been extended through professionalization to areas of 
service that had previously come under other categories of everyday life such as giving birth, 
child rearing, and schooling (Zola, 1972; Foucault, 1973).  
By contrast, one further line of inquiry, derived from a series of historical papers and 
books on medical specialties, was critical of the Anglo-American bias in sociological models of 
professionalization that focused on a strong degree of autonomy and self-governance among 
professionals and “analytical categories that appear to transcend the experience of particular 
professions” (Johnson, 1975: 186-7; cf. Shortt, 1983; Burnham, 1996). A different trajectory of 
professionalization, the historians pointed out, had occurred in Europe and elsewhere in which 
professional functioning had been largely affected by state control of resources and policies 
(Shortt, 1983; Geison, 1984: 2-3; Burrage, 1990; McClelland, 1991: 11-27). Authors 
consequently set about isolating for closer scrutiny the histories of significant institutions and 
groupings of practitioners who were self-identified as professionals at the national and/or local 
levels. Institutions and their members, it was argued, were not the by-products of 
professionalization but, rather, could be viewed as “an evolving set of solutions to changing 
problems” (Pernick, 1978: 1029).  
Specifically with regard to the subject of the specialization process and the collective 
character of the medical profession, authors in the fourth line of inquiry have made a strong case 
for making a distinction between the medical specialization of the nineteenth century and the 
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specialization that takes place in the decades leading up to and following, roughly, 1950 (Geison, 
1984; McClelland, 1991; Weisz, 2006 cf. Crosland, 1977; Burnham, 1998). The stages of 
development and periodizations that emerge shift focus away from the themes of encroaching 
bureaucratization and professional control. The emphasis is rather on the styles, function and 
consequences of medical research and teaching on innovation in clinical practice. Specialization 
in nineteenth-century medicine is associated with innovations in laboratory research and the 
training of general practitioners (Weisz, 2006: 3-63, cf. Shortt, 1983; Ramsey, 1984). And the 
major locus for empirical study here is the combination of medical school and teaching hospitals. 
Specialisms become the dominant form of medical practice and take away from earlier forms of 
“general” practice. More particularly, new approaches to professional training and certification 
emerge alongside new ways of framing the regulation and standardization of health care 
practices. As George Weisz (2006: xvi-xvii) observes, medical specialization “evolved from a 
largely local to a national phenomenon, producing new kinds of specialist associations, 
transforming the institutions of the larger medical profession, and, in some cases, becoming an 
issue for political authorities.” Additionally, he notes, since the 1960s, “many new specialties and 
subspecialties have grown out of innovations produced by the academic research sector 
(reproductive medicine, medical genetics), while others are the consequence of what are 
perceived as new social needs (family and adolescent medicine, geriatrics)” (2006: 231). 
Specifically, and with a view to the ideas of evolving stages of development and 
periodizations, I examine in this paper how a range of medical interests were brought together 
around:  (1) Mendelian genetics and the adoption of probability and statistics as scientific 
methods of quantifying the risk of heritable disease; (2) the acceptance by medical academia of 
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probabilistic and new multifactorial models of disease aetiology; and (3) the negotiated protocols 
and standards of medical practice worked out by bodies such as the relevant royal colleges, the 
linked associations and societies for medical professionals, affected training and research 
authorities, and government.  
The Medico-scientific Background of Medical Genetics  
in North America and the UK 
 
The available histories suggest that although the study of genetics gained scientific acceptance 
between 1915 and 1930 in Norway, Sweden, Denmark, the United States and the Soviet Union, it 
was less well received in Germany, and quite poorly received in the United Kingdom and France 
(Allen, 1978: 278-283; Harwood, 1993: 143-56). By and large, European scientists were more 
interested in studying the grander Darwinian theories of evolution and trained in descriptive and 
qualitative methods of research (Sapp, 1983; Rushton, 2000). Those supporting the new 
probabilistic reasoning of Mendelian theories of genetics tended to have a background in 
experimentalism, and were more likely to be found in the agricultural and social sciences, and in 
disciplines such as demography, vital statistics, and agricultural science. 
The term “medical genetics” first appeared in articles written by Madge Thurlow Macklin 
(1932, 1933), then teaching histology and embryology at the University of Western Ontario.  The 
term also appears in books written by John A. Fraser Roberts (1940), then Principal Investigator 
at the Burden Mental Research Department, Stoke Park Colony, Bristol, and Laurence H. Snyder 
(1941), then professor of medical genetics at Ohio State University. These publications were 
ostensibly introductions to applied human genetics for medical students and physicians. At no 
time, however, do the early authors on medical genetics qua geneticists claim to be specialists in 
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the field of medicine. They are, rather, appreciative reporters of innovations in science. Common 
concerns, nonetheless, are evident and all have to do with the perceived need, first, to close the 
gap between theoretical and clinical capability in the application of genetics-based knowledge in 
clinical practice, and, second, to educate individuals about the practical uses of genetic theory in 
medicine.   
Daniel Kevles (1985:205) has indicated that fewer than two hundred people published 
any research in the early Anglo-North American contingent of human geneticists. Of these, fewer 
than fifty published more than once. The situation changed noticeably after the Second World 
War. Formal positions for “human geneticists” had been created in thirty-one centres in the 
United States (twenty-five), Canada (four), and England (two) by the end of the 1950s (Leeming, 
2004: 483-4). But little is actually known about the contents of early human genetics research 
and teaching in Anglo-North American universities and colleges. What we do know is that the 
Association of American Medical Colleges (AAMC) in North America sponsored the first 
organized efforts to gather information on the extent of genetics instruction in medical schools as 
early as 1946 (Leeming, 2004: 484-6). An AAMC report on of a 1954 workshop on “Objectives 
of Teaching” is of particular interest for the unexpectedly high levels of demand indicated for 
genetics instruction in medical schools (Subcommittee on Objectives of Teaching, 1955). 
Moreover, the discussion generated by the recommendations of the Report appears in a number 
of later surveys and reviews on the subject.2  
Clinical techniques involving the identification of hereditary factors in disease are 
described in the Report as supplementing the practices of “any [medical] specialty that can be 
named” (1955: 19). Turning to the question of who should teach genetics, participants in the 
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workshop generally agreed upon “a trained medical geneticist on the staff” who “could also have 
service and research functions” (1955: 21-22). Thus, a multi-faceted role is envisioned for 
medical geneticists working in North American teaching hospitals. As a “staff geneticist,” the 
medical geneticist would provide clinical consultation and physical examination with respect to 
cases of: birth defects, known inherited disorders in families, multiple miscarriages and 
stillbirths, mental retardation (where cause is unknown) or developmental delay, growth 
disorders, dysmorphological features, and ambiguous genitalia or abnormal sexual development.  
Comparatively speaking, five subsequent surveys, completed over a period of three 
decades, show that the proportion of medical schools with formal courses in genetics increased 
from 8.6 per cent in 1953 to 86.5 per cent in 1985.3  At the same time, three of the surveys 
indicated that, rather than an integrated curriculum, genetics instruction increasingly became the 
preserve of paediatricians and geneticists working in independent genetics departments. This 
matter went on to be described in reviews and surveys as an interdisciplinary problem; a problem 
frustrating the larger goal “that ‘genetically thinking’ becomes an integral part of [all] medical 
practice” (Motulsky, 1979;  Hickman, 1981: 246). From this emerged what I (2001: 468-69; cf. 
Yoxen, 1982) have elsewhere called a bifurcated ideological construct that shaped and informed 
the means of organizing what was being called a “genetics-based approach” to disease.4 The 
construct stipulated, on the one hand, that the mandate of medical genetics was to add a new set 
of medical procedures to the clinical repertoire of all health disciplines. On the other hand, it 
indicated that when and where service providers were unable to deliver the new procedures, a 
class of specialists (i.e., medical geneticists) would be available for consultation. 
A useful observation to be made at this point about “medical genetics” 
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character after 1950; that of an elementary albeit synthetic development in medical training and 
academic research. Interviewees in the cross-national study I am completing on medical genetics 
in the UK and Canada have described a kind of Mertonian science community, and the type of 
specialized work associated with the geneticist in clinical practice recalls what Victor Thompson 
(1964:25-7) described as “personal specialization.” 
In Merton’s science community, the reader will recall, the exchange of expert knowledge 
is straightforward and non-repetitive across a market interface that requires little in the way of 
social infrastructure (Merton, 1973; cf. Hagstrom, 1965; Storer, 1966).  Scientific labour entails 
broad-based, undirected research that is usually conducted in universities under the volition of 
the individual researcher, passed on to society through peer-reviewed journals and other forms of 
knowledge transference, which leads in turn to goods and services. The production of knowledge 
is driven by a self-contained reward system: the researcher gains prestige in the scientific 
community and his/her commitment is sustained through intradisciplinary control of status and 
entitlements more than monetary rewards (e.g., academic appointments, formal titles, weighted 
indices of publications, authorial citations, etc.). At the same time, the rate and direction of 
knowledge production remains unpredictable, and involves the play and capriciousness of 
scientists’ personal interests. Specialist behaviour thus arises from the person, and not the task 
(Thompson, 1964:27).5 Using Thompson’s nomenclature, there was high personal specialization 
in the medical genetics of the 1950s, but only one operative role, i.e., the geneticist in the 
teaching hospital setting.
Individuals interviewed for my study reported that the circumstances of medical 
geneticists changing significantly after the 1950s. According to interviewees, new kinds of 
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working relationships appeared, and occupational roles and work rules changed. All interviewees 
pointed to technological innovations in the form of new laboratory technologies for identifying 
chromosomal anomalies and genetic metabolic disease as driving the rate and direction of 
changes in the workplace. More particularly, local associative strategies surrounding specialty 
formation and the institutionalization of medical genetics in North America and the UK would go 
on to emphasize multidisciplinary task specialization among genetic health care providers and 
more or less continually unfolding internal differentiation among academic health centres, 
community clinics, consumer and voluntary groups, government agencies, and public health 
departments. That said, in contrast to the UK and Canada, a broad cohesive national plan for 
building a genetic health service delivery infrastructure in the United States never appeared (cf. 
Lin-Fu and Lloyd-Puryear, 2000; Centres for Disease Control and Prevention, 1997).  
Medical Genetics: The Canadian Case 
Fiona Miller’s study (2002) of early developments in Toronto throws highlight on Norma Ford 
Walker’s accomplishments in the field of dermatoglyphic pattern analysis. Indeed, following the 
discovery of the chromosomal basis of Down’s syndrome in 1959, scientific interest in dermal 
patterns intensified, and pattern analysis was recognized as a useful method for diagnosing patients 
for chromosome analysis (Thompson and Thompson, 1966: 245-6). But what is problematic here is 
Miller’s claim that Walker’s research was “marginal” and that she was involved in establishing a 
“school” of medical genetics. In actuality, Norma Ford Walker had little interest in medicine per se.6 
Trained as an invertebrate zoologist at the University of Toronto; she gained considerable notoriety 
in science circles for her work on the dermatoglyphics of the Dionne quintuplets, the first quintuplets 
known to survive infancy.7 Contrary to Miller’s characterization of this work as “iconoclastic 
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genetics,” the study of the quintuplets completed in 1937 was a significant contribution to 
contemporary studies of “mental likeness” in twins and intelligence testing. The importance of twin 
studies, especially monozygotic twins (i.e., from “one egg,” identical) and reared together, was 
widely viewed as proof positive of the perdurability of human nature (Gould, 1981: 234-320). More 
particularly, the Dionne study lent credible support for Gesell’s proposition that even the most 
identical twins had inbred differences that could become more or less profound according to motor 
training and mental stimulation (Gesell and Thompson, 1929).  
Norma Ford Walker’s subsequent appointment as a genetics consultant in 1940 at the 
(Toronto) Hospital for Sick Children, entailed a kind of resource exchange relationship: Hospital 
clinicians would send patients and families to her. She would calculate patterns of hereditary 
transmission and counsel the families on issues relevant to family planning and the recurrence of 
familial traits. In return, she was permitted to freely pursue her own research interests, along with 
those of her students, in the hospital. It is important to note, however, that the hospital’s 
arrangements for Walker’s services never included laboratory supports. Thus, Ford Walker’s 
successors encountered a fragmented set of service operations that had failed to keep pace with other 
genetic services in North America. In actuality, a fully integrated Division of Clinical Genetics, 
jointly responsible to the Department of Genetics and the Department of Paediatrics, did not appear 
in Toronto until 1986. 
 Cumulative links between genetics and specialized areas of medical research and services can 
be recognized more easily in developments at McGill University in Montreal (Leeming, 2004: 488). 
The interwar years saw well-known figures such as the English hereditarian H. B. Fantam as 
McGill’s Strathcoma Professor of Zoology, and a brief stint of teaching by Lancelot Hogben, who 
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went on to become professor of social biology at the London School of Economics. In 1934 an 
independent department of genetics was formed. There had been disagreement at the university level 
between the departments of zoology and botany about who should teach undergraduate genetics. The 
dispute was resolved by way of receiving a Rockefeller Foundation grant to start up an independent 
genetics department. The first chair was C. Leonard Huskins, a plant geneticist who also consulted 
with local physicians on Mendelian disorders. In 1949, F. Clarke Fraser, a PhD-geneticist in his final 
year of medical school, was asked to set up a genetic counselling service at the Montreal Children’s 
Hospital. This came as a result of negotiations between J. Wallace Boyes, Huskins’s successor at 
McGill, and Alton Goldbloom, the hospital’s chief of paediatrics. A department of medical genetics 
was formally approved at the hospital in 1951, with a modest staff consisting of Fraser and an 
assistant. 
Developments of the sort described above at Toronto and Montreal can reasonably be viewed 
as starting points for later developments in Canada. Of the fifteen sites in Canada that provided some 
combination of medical genetics training and services by the end of the century, eight (Edmonton, 
Vancouver, Winnipeg, London, Montreal [Ste-Justine], Quebec City, Hamilton, Kingston) were set 
up by individuals who had studied in Toronto and Montreal. The remaining five sites (Saskatoon, 
Ottawa, Halifax, Calgary, St. John’s) were set up by individuals who originally trained in the UK. 
Only two of these received training in genetics in the UK, however. One trained in Canada, another 
in the United States, and a third “picked it up on the job” (Leeming, 2004: 488). Thus, Toronto and 
Montreal figure into the story of medical genetics in Canada as key sites of information exchange 
and genetics training. But, then again, this was a period when there were few referrals of patients for 
genetic counselling. The exchange of information about genetics was pursued largely in terms of 
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teaching and research interests by individuals who only provided counselling when called upon to do 
so. What’s more, one has to consider how important links with the United States were for collegial 
support and approbation. 
  Diane B. Paul (1988: 137) and Daniel Kevles (1985: 199, 208-9, 252-4) have indicated that 
in the two decades following the Second World War “virtually all institutional patrons [in the United 
States] of work in medical genetics and genetic counseling also had eugenic motivations.” 
Specifically, attention is drawn to support from the Rockefeller, Carnegie, Wenner-Grenn, 
McGregor, and Rackham foundations, the Commonwealth and Pioneer Funds, and the American 
Eugenics Society. Canadian geneticists, by contrast, did not enjoy this kind of support during this 
period (McLaren, 1990: 90-1, 99-106, 108, 112-115). As noted above, the genetics department at 
McGill had received some start-up funding from the Rockefeller Foundation. But this was the 
exception.  
It was the American Society of Human Genetics, established in 1949, which provided 
Canadian geneticists with opportunities to meet and exchange information with like-minded fellows 
on an intra-continental level. The idea for the Society was proposed at an informal gathering in 
December 1947 held during the meetings of the American Association for the Advancement of 
Science at Chicago. Within five years the membership had grown to 565 individuals with 316 
institutional subscribers to the journal.8 Americans made up 84 per cent of the membership at the 
time. Of the remaining 16 per cent, 5 per cent were Canadians. That said, of the 27 Canadian 
members, 25 were from Ontario and Quebec. And 14 of these individuals were affiliated with the 
University of Toronto (9) and McGill (5). Moreover, from the start, Canadians served as directors of 
the Society and editors of the journal. 
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A wholesale shift in the importance of “eugenics” for medical professionals interested in 
genetics followed certain irreconcilable differences at the American Society of Human Genetics 
between the ameliorism of the eugenic practices and what was being presented as the value-free 
science of human genetics. This shift found its expression most forcefully in what Sheldon C. 
Reed, director of the Dight Institute of Human Genetics, called “non-directive genetic 
counseling;” a procedure intended to explain to patients “what the genetic situation is … but the 
decision must be a personal one between the husband and wife, and theirs alone” (Reed, 1955: 
14-15). Non-directive genetic counselling, in the context of a medical service provided by staff 
geneticists (à la the 1954 American Association of Medical College report), was to be viewed in 
terms of a contract for services and the essence of the physician-patient relationship would be 
transformed from one of status to one of contract.  
Importantly, the movement to formally standardize genetic counselling services was linked to 
changes in the clinical division of labour, changes that were integrally linked to the development of 
new diagnostic tests and laboratory services in the 1960s. The first development involved the 
investigation of chromosomal abnormalities. Human chromosomal analysis in the 1950s and 1960s 
involved techniques largely developed in cytological studies of animal and plant species carried out 
in the 1920s and 1930s. Improved methods during this period made it easier to count human 
chromosomes and to study their morphology. This, in turn, permitted some types of chromosomal 
abnormalities, including missing or extra copies of a chromosome or gross breaks and rejoinings 
(translocations), to be detected by microscopic examination. The presence of an additional small 
acrocentric chromosome in typical cases of Down’s syndrome was first reported in France in 1959 
and quickly followed by reports from cytological laboratories in England (Lejeune et al., 1959; cf. 
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Ford, Jones et al., 1959; Ford, Polani et al., 1959). The publication of these findings in quick 
succession during 1959 caused a sensation among scientists and clinicians alike (e.g., Stevenson, 
1961). The development of human cytological genetics or “cytogenetics” provided, for the first time, 
clinical tools to uncover the genetical make-up of relatively common disorders associated with 
mental illness. 
Lejeune’s announcement of the discovery of trisomy 21 and Down’s syndrome took place 
at a seminar in the McGill University genetics department in 1958, following the meetings of the 
International Genetics Congress at Montreal that summer. Jacques Gagnon, a pathologist at 
Université de Montréal, went to study with Lejeune in France and then brought cytogenetics back 
to Montreal at l’Hôpital Ste-Justine in 1959. Cytogenetics was established at McGill the 
following year when Louis Dallaire set up a laboratory to study chromosomal translocations for 
his PhD research under the supervision of Clarke Fraser. Fraser, who was also the geneticist on 
staff at the Montreal Children’s Hospital, subsequently asked Dallaire to develop a service 
laboratory for the hospital in 1964. A succession of regional cytogenetic services quickly 
followed in other provincial teaching centres: University of Alberta Hospital at Edmonton 
(1962); Department of Paediatrics, University of Saskatchewan at Saskatoon (1964); Ottawa 
Civic Hospital (1965); Department of Pathology, Queen’s University at Kingston (1968); 
Children’s Hospital of Manitoba at Winnipeg (1969); Foothills Hospital at Calgary (1969); and 
Izaak Walton Killam Hospital at Halifax (1970).  
A parallel development to chromosome analysis, biochemical testing, provided new ways 
of identifying genetic events by revealing abnormal metabolites in body fluids. After 1960, the 
basic division of labour involved in biochemical testing followed a pattern similar to that of 
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chromosome analysis: individuals with backgrounds in chemistry were recruited to perform a 
service function in “biochemical laboratories,”, and a new occupational category appeared, 
“biochemical geneticists.” Physicians would look for tell-tale signs and symptoms (e.g., failure to 
thrive, developmental delay, ocular abnormalities) that might be indicative of metabolic disease. 
A geneticist would be consulted regarding the family history and, if a laboratory evaluation was 
in order, blood or urine was obtained and shipped to the laboratory where it would undergo 
testing. A laboratory report would be returned to the consulting physician with information about 
a geneticist who was available for consultation. 
The movement to introduce newborn screening programs in the provinces began when a 
simple and inexpensive metabolite inhibition assay was developed in the United States to detect a 
treatable metabolic disease. The test, combined with a treatment (dietary phenylalanine 
restriction), had led to a highly successful therapy for phenylketonuria. Therapeutic and/or 
curative interventions followed for galactosaemia, congenital hypothyroidism, 
aminoacidopathies, fructose intolerance, tyrosinaemia, and other metabolic conditions. Newborn 
screening programs for these conditions were subsequently set up in nine provinces, between 
1963 and 1969, largely administered through provincial public health programmes (Leeming, 
2004: 492-3). Only in Quebec did geneticists take a proactive role in the organization of a 
province-wide program (Leeming, 2004: 493). 
Despite the fact that Canadian newborn screening services came mostly under the 
purview of public health branches and departments of health and community services, laboratory 
and counselling services were provided by the genetics departments in teaching hospitals. In 
addition, geneticists experienced increases in workload as techniques for culturing foetal cells 
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from amniotic fluid were refined and amniocentesis became useful as an outpatient procedure for 
obtaining test samples for chromosomal and biochemical analysis from pregnant women. 
Obstetricians performed all the amniocentesis procedures. Geneticists provided pre-procedure 
counselling to inform the patient of the risks associated with the procedure. The geneticists 
would also schedule when and where the procedure was offered. Furthermore, the geneticists 
would review test results and provide counselling in the event of a positive result. 
The first concerted effort to monitor the rate and direction of genetic counseling and 
laboratory services was mounted in the early 1970s when Canadian geneticists realized that they 
were spending proportionally less time in the classrooms and labs and more time in the clinics. 
Members of the Genetics Society of Canada established a committee in 1971, the Committee on 
Genetics as it Relates to Social Problems, with a mandate to examine standards of care, payment 
for services rendered, and the training and accreditation of service providers. A survey by 
questionnaire of twenty-two individuals known to be providing genetic services in thirteen cities 
(Toronto, Montreal, Quebec City, Vancouver, Victoria, Ottawa, Kingston, London, Hamilton, 
Winnipeg, Edmonton, Saskatoon, Halifax) confirmed that an increase in demand for genetic 
counseling had occurred and attributed the increase to innovations in laboratory and obstetric 
services (Miller, 1972). The survey showed that the costs of laboratory services were not directly 
reimbursed through provincial health care insurance schemes. Costs were largely paid for with 
research funds, or were being absorbed through hospital global budgets. 
The problems identified in the survey were made the focus of an informal meeting two years 
later that was organized as part of the 1973 annual conference of the Genetics Society of Canada in 
North York, Ontario at York University. It was here that the idea of creating a formal mechanism to 
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maintain standards of genetic services first surfaced. In a statement prepared by the “Committee on 
Genetics as it Relates to Social Problems” (1973), and approved by the Genetics Society of Canada 
Executive, a recommendation was made that the Society lobby the appropriate federal and provincial 
government authorities, first, to acknowledge genetic counselling was an important health service, 
and, second, to develop a means of accrediting the centres offering laboratory and counseling 
services. Further to this, multi-disciplinary centres were described that would integrate PhD-
geneticists (i.e., non-physicians) into clinical practice. Interviewees for the present study who 
participated in the meeting said that they were deliberately trying to topple Royal College restrictions 
surrounding who and who could not provide patient care.9 What emerged from all this was a 
coalition to form a corporation to be known as the Canadian College of Medical Geneticists. 
A proposal to create the Canadian College of Medical Geneticists was presented to an 
assembly of thirty-three individuals who were invited to attend a three-day meeting at the Guild Inn 
in Scarborough, Ontario in November of 1974. All attendees were providers of genetic services and 
nine provinces were represented. A statement from the Steering Committee (1975) followed in the 
April 1975 issue of The Genetics Society of Canada Bulletin declaring the proposed College was 
“not a scientific society such as the Genetics Society of Canada, but an organization concerned with 
the establishment and enforcement of professional standards on health care delivery in the field of 
Medical Genetics.” Later statements asserted that the College would consist of and represent “those 
properly qualified PhDs and MDs” and affirmed “that individuals with a PhD have a role to play in 
delivering genetic services.” The delivery of services would be associated with medical centres 
where physicians trained in medical genetics would provide patient consultation. The centre would 
assume responsibility for monitoring the quality of the laboratory services and accreditation 
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evaluations would be formulated by the Canadian College of Medical Geneticists. 
The application for the incorporation of the College was recorded by the Ministry of 
Consumer and Corporate Affairs on January 13, 1976. The initial focus was on recruiting as 
members a fair representation of individuals in active clinical practice. A special dispensation was 
devised to grandparent individuals deemed to already possess sufficient knowledge and skills to be 
considered Fellows of the College. Additionally, in 1976, the Board courted controversy by 
submitting a proposal to the Royal College of Physicians and Surgeons (Canada) requesting the 
formation of a sub-specialty in medical genetics. Despite the concern of many members that PhD-
geneticists might get left behind if such an application were accepted, the College of Medical 
Geneticists and the Royal College pursued a series of negotiations over the next decade that would 
ultimately change the course of delivering genetic services in Canada.  
In 1981, the College formally declined an offer made by the Royal College to grant a 
certificate of special competence in medical genetics to Fellows of the Royal College certified in 
either paediatrics or internal medicine as their primary certification. However, members continued to 
talk informally to individuals on the Royal College’s Committee on Specialty Development while, 
simultaneously, making inquiries with the provincial licensing bodies about the Canadian College of 
Medical Geneticists becoming some kind of national accrediting body. It was in fact not until 1988 
that the Specialty and Manpower Committee of the Royal College supported the creation of a free-
standing specialty with a five-year training program. The recommendation was approved by the 
Credentials Committee and Royal College’s Council so that, in 1989, medical genetics attained 
status as one of fourteen clinical specialties recognized by the Royal College’s Division of Medicine. 
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there were eighteen centres in eight provinces that provided counselling and laboratory services. All 
belonged to university-hospital affiliated programs, with the exception of three centres in Ontario 
(Oshawa, Credit Valley, North York). In addition, nine provinces had established outreach programs 
whereby staff from genetics centres was dispatched on a regular basis to hold clinics sites in outlying 
areas. As a final point, it is worth noting that the role of PhD-geneticists was overturned in terms of a 
clinical role in medical genetics during the process of specialty formation. PhD-geneticists continued 
on in the field with respect to teaching human genetics in university medical faculties and with 
respect to the delivery of laboratory services independent of the counselling services.  As a rule, 
however, they ceased to counsel patients or administer regional genetics centres in Canada.  
Medical Genetics: The UK Case 
By all accounts, the average physician in the UK was not terribly interested in genetical 
explanations about the relationship between heredity and disease causality until well after 1960. 
Indeed, David Lewis’s survey of the membership lists of the Genetical Society of Great Britain 
shows a sharp increase in members involved in medical research after 1959, rising steeply to 
1969 when nearly 12 per cent of the 900 members of the Society were working in medicine 
(Lewis 1969: 5-6). Lewis attributed this increase to technological advances in human cytological 
research and work being done in the area of chromosomal abnormalities in humans. He also cited 
the research surrounding the Rh blood group and haemoglobin variants being done at the 
National Institute for Medical Research, Lister Institute, Chester Beatty Research Institute; and 
the Medical Research Council units in the UK. 
By 1964 there was sufficient medical interest in a genetical understanding to disease to 
sustain both a specialist journal, Journal of Medical Genetics, and a new society, the Clinical 
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Genetics Society. Initially, the Clinical Genetics Society represented a kind of divided nucleus 
within the emerging field of medical genetics; a polycentric structure with multiple bases of 
interest (Leeming, 2005: 547-51). At the most basic level, the Society was divided along lines of 
primary specialization, although the area of paediatrics came into the foreground with the 
Society’s early recommendations on the training of clinical geneticists in the early 1970s. The 
Paediatric Specialist Advisory Committee of the Royal College of Physicians supported a 
resolution that the Member of the Royal College of Physicians (MRCP) would be considered by 
them to be an essential qualification for genetic service providers, as it was then for consultants 
in every other branch of clinical medicine. The Advisory Committee’s recommendations 
followed a particular line of logic: parents with a family history of hereditary disease or 
congenital malformations were traditionally counselled by paediatric specialists with expertise in 
the care and treatment of diseases and disorders of the newborn. Furthermore, the new testing 
regimes of the 1960s for identifying chromosomal anomalies and metabolic diseases had 
widened the remit of genetic consultation within paediatrics. And geneticists were clearly 
experiencing increases in workload with the work associated with new programs in newborn 
screening, mid-trimester amniocentesis and antenatal diagnosis. 
At the same time, the membership of the Clinical Genetics Society had a varied 
background including specialists in ophthalmology, psychiatry, obstetrics and general practice – 
fields that were not branches of clinical medicine under the Royal College. Having the MRCP as 
a training requirement, many believed, would be too restrictive and potentially hold back the 
development of a genetics-based approach to health care in clinical specialty areas other than 
paediatrics. Further to this, concerns were raised about the evolving relations between clinical 
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and laboratory personnel. Some members went so far as to suggest that training for medical 
genetics should require the MRCPath. In other words, geneticists should run laboratories under 
the control of departments of pathology and also see patients. Alternatively, others suggested 
separate roles for the clinician and scientist, advocating a formal association be made between 
clinical genetics, cytogenetics and biochemical genetics, In the end, the arguments and debates 
resulted in a breakup within the Clinical Genetics Society. The cytogeneticists, fearing a 
paediatrics-dominated Society would exclude non-physicians, split off and formed their own 
body, the Association of Clinical Cytogeneticists. The Association became an interstitial 
organization that arbitrated in matters concerning the research and service functions of 
cytogenetic laboratories. This set the example, much later, in 1988, for a third body, the Clinical 
Molecular Genetics Society, representing scientists interested in diagnostic applications of 
molecular genetics.10 
In 1978, Alan Johnston, reporting on the findings of the Clinical Genetics Society’s ad-
hoc working party on the training of medical geneticists, remarked that although the chance 
convergence of different disciplines into the field of human genetics had resulted in a number of 
spectacular contributions “which have had repercussions through the whole science of genetics,” 
and medical genetics had progressed to the point where highly specialized training and 
professional standards of practice were now necessary (Johnston, 1978). Citing the example of 
the recently incorporated Canadian College of Medical Geneticists, the UK working party set out 
to recommend standards of health service delivery. The medical geneticist of the future would 
have four main functions; 
… to contribute to diagnosis (including antenatal); to counsel patients and their relatives; to 
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maintain genetic registers; and to act as consultant to cytogenetic, biochemical, and other 
relevant laboratories. In short, he or she would be responsible for organizing a comprehensive 
genetic advisory service. Additional functions would be involvement in teaching and research, 
which would be particularly important since he would be working mainly in major centres, 
usually teaching hospitals. Thus a joint NHS/university appointment at consultant level to a 
Genetic Advisory Centre is preferable (Johnston, 1978: 260). 
 
The role of the medical geneticist and the creation of regional genetic services were topics 
pursued in detail by the Clinical Genetics Society in two subsequent working parties 
(Fitzsimmons, et al., 1982; Harris et al., 1983). The Royal College of Physicians became 
involved, initially through the work of the Medical Genetics Sub-Committee of the Paediatric 
Specialty Advisory Committee and, in 1984, with the formation of a standing Committee on 
Clinical Genetics. Both the Medical Genetics Sub-Committee and the standing Committee were 
largely made up of members of the Clinical Genetics Society. 
As in the Canadian case, the initial inquiries into the status of genetic diagnostic and 
laboratory services in the UK showed that there was considerable variation in the range of 
services offered from region to region and much of what made up service arrangements was 
largely dependent on university and research funding. Geneticists offering these services, on the 
other hand, were clearly willing to cooperate with government programs for integrated services 
so long as sufficient resources were made available.11 The Clinical Genetics Society 
consequently set up working parties in the 1980s who in turn endorsed an “integrated regional 
genetics service” that would act as the “focus to which the primary health care team, hospital 
consultants and other specialists should direct particular problems relating to inheritance, 
including the diagnosis and prevention of birth defects” (Fitzsimmons et al., 1982: 2). Moreover, 
each service centre would set up computer registration of genetic diagnostic information (genetic 
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registers) for the express purpose of tracing, following-up, and counselling individuals at risk of 
having or transmitting a serious genetic disorder. These centres would, in accordance with the 
organizational structure of NHS Regional Health Authorities, serve a population of 1 ½ to 3 
million and would, on this basis, provide for several District General Hospitals. The rationale for 
the allocation of catchment areas was based on the calculation of the proportion of, first, 
congenitial malformations and, second, chronic disease with a major genetic component. In 
addition, the 1983 Working Party envisaged programmes to extend counselling to district general 
hospitals through regular visits by centrally based whole-time clinical geneticists (Harris et al., 
1983: 22). Local clinicians would prepare information on patients in advance of the “satellite” 
clinics and visiting clinical geneticists would share after-care responsibilities with family 
practitioners. 
At a high level of generality, the formal structure for the integrated genetics service 
proposed by the Clinical Genetics Society fit well within the regimes of service delivery 
instituted between 1974 and 1982 when the National Health Service was reorganized to integrate 
hospital, community health care and family practitioner services under a unified management 
structure. By 1982 genetic laboratory services and counselling clinics were to be found in 
nineteen NHS regions across the UK. The “regional genetic service” became the hallmark of 
British medical genetics, holding regular clinics in the centre and also satellite clinics to which 
clinicians would be dispatched to see patients in District General Hospitals. The organization of 
the genetics centres themselves would follow along the lines of the multidisciplinary centres 
established earlier in Canada – but with noticeable differences. Consultants (i.e., clinical 
geneticists) were responsible for genetic counselling and syndrome identification for all referred 
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individuals. Correspondingly, there was close collaboration between the clinical geneticists and 
the heads of laboratories in the areas of, initially, cytogenetics and biochemical analysis and, 
later, molecular analysis. Both clinical geneticists and scientists participated in the administration 
of services as well as in the forward planning of genetics services at the regional level. 
Discussion:  Professionalized Human Geneticists,  
Specialization, and Networked Innovation  
  
“One of the main difficulties in dealing with the new genetic technologies,” Lassen and Jamison 
have perceptively noted in their study of public opinion on the subject, “is that they are solutions 
in search of problems” (2006: 8). Genetic technologies have not been developed to cure diseases, 
they observe, “even though such claims are often made on their behalf” (ibid.). Nonetheless, we 
tend to see geneticists as major players in the future of science and medicine. And we take very 
seriously the implications of their work for our futures. This last point is well-illustrated in the 
collection of papers brought together for this special issue of the CRSA, Genes and Society: 
Looking Back on the Future.  
In this paper, I began by describing how a range of medical interests came together 
around the adoption of probability and statistics as scientific methods of quantifying the risk of 
heritable disease and the acceptance by medical academia of probabilistic and new multifactorial 
models of disease aetiology and genetics. Until the 1950s, medical interest in human genetics 
was confined to personal specialization (à la Thompson) and the capriciousness of individual 
scientists and clinicians. With time, formal recognition of the term “medical genetics” took hold, 
spurred on by a growing number of supporters, a narrow base of original conceptual unity, and 
the emergence of new laboratory technologies, around 1960, for studying chromosomal 
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anomalies and tests for genetic metabolic disease. These general-purpose technologies fueled the 
vigorous and sustained growth of genetic health services and were clearly implicated in 
significant changes in health care delivery systems. This included driving the rate and direction 
of changes in the workplace. An intrinsic technical logic and language evolved in the 1960s that 
provided a kind of lingua franca  spoken by providers of “genetic health services.” After 1970, 
local associative strategies surrounding specialty formation and the institutionalization of 
medical genetics in Canada and the UK would go on to emphasize, first, multidisciplinary task 
specialization among genetic health care providers and, second, more or less continually 
unfolding internal differentiation among academic health centres, community clinics, consumer 
and voluntary groups, government agencies, and public health departments. Medical genetics as 
a specialism consequently gained a semblance of unanimity over its basic reference points and 
arrived at a meaning directly tributary to current acceptance of the term.
But such a bald description actually tells us little about the heterogeneity of genetics-
based health services in Canada, the UK, and elsewhere. Medical genetics is, of course, itself an 
occupational category and thus predicated on “insider-outsider” relations. Generally speaking, the 
medical geneticists studied in this paper claim the genetics-based approach to illness as their area 
of expertise (i.e., a “jurisdiction”  la Abbott). But, at the same time, the “genetics-based 
approach” to illness operates as a bifurcated ideological construct that shapes and informs a 
wider range of practices. The construct stipulates, on the one hand, that the mandate of medical 
genetics is to add a new set of biomedical procedures to the clinical repertoire of all health 
disciplines. On the other hand, it points out that when and where service providers are unable to 
deliver the new procedures, a class of specialists (i.e., medical geneticists) are available. 
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Indeed, specialists in other areas of medical practice have increasingly come to see to the 
treatment and medical management of patients with numerous genetics-based components, often 
providing information to patients concerning “the genetics” of the condition at hand (Hedgecoe, 
2003; Kerr, 2004; Cox and Starzomski, 2004). This may be viewed as evidence of competing 
segments and jurisdictional disputes; as an encroachment on the medical geneticists’ claim to 
jurisdiction. But medical geneticists themselves do not view the situation this way. Generally 
speaking, they see other specialists coming around to their way of thinking; as adopting a 
genetics-based approach. The argument goes something like this: In the first place, the 
jurisdictional interface with other specialties has been reinforced and strengthened by innovations 
and routines in applied human genetics. Networked innovation and the circulation of standards of 
laboratory and clinical practice (i.e., a genetics-based approach to medicine) can be seen to 
diffuse horizontally across a large number of specialty areas, as its advantages apply to different 
activities. As awareness of the genetics-based approach to illness increases in medicine globally 
(i.e., in general), collegial recognition of the expert role of the medical geneticist in medicine is 
fortified. Medical genetics is therefore inclusive as opposed to exclusive in the occupational hub 
culture of medical professionals.12 
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Notes 
                                                 
1
 The material that follows draws on findings reported in two earlier papers (Leeming, 2004; 2005). 
Two kinds of data are used in the comparative case study. Preparatory research was based on the 
analysis of primary and secondary source materials drawn from a range of libraries and archives. In 
addition to providing technical details and facts, this material furnished a source of general 
information about practical genetics applications against which to compare the responses 
forthcoming in interviews – the second source of data for this study. Open-ended qualitative 
interviews began in April 1997 in Canada and the UK. To date this has involved a sample of one 
hundred and sixty-four interviewees. 
2
 See, Neel (1957), Hickman (1981), Childs, Huether and Murphy (1981), Childs (1982), Davidson 
and Childs (1987), Riccardi and Schmickel (1987), Graham, et. al. (1989). 
3
 See, Levine, Gursky and Rimoin (1977); Robertson and Haley (1946); Herndon (1954); Childs, 
Huether and Murphy (1981); Riccardi and Schmickel (1987). 
4
 Following the example of Robbins and Johnston (1976: 353), I use the term “ideology” in a 
restricted sense. It refers only to “those systems of closely related beliefs, ideas and attitudes” that 
exist among the groupings of medical professionals and scientists studied in this article. It is not here 
used in its broader sense, i.e., as a Weltanschauung. I am interested only in how geneticists make 
sense of medical genetics and seek to further their collective professional aims. This can be 
contrasted with, for example, what the historian Susan Lindee has called “genetic essentialism” and 
“genetic folklore.” Lindee’s interest is in how notions from popular culture influence technical 
conclusions and the establishment of facts in the culture of medical science (2006: 7). 
5
 In Thompson’s schema, specialization of tasks refers to work specificity, i.e., “making activities 
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more specific” (1961:25). By contrast the specialization of people refers to the adaptation of the 
individual to environmental circumstances. 
6
 Norma Ford Walker passed away in 1968. Much of the background information concerning 
Walker was provided to me in personal interviews and subsequent communications with her 
students. 
7
 Born in Corbeil, Ontario in 1934 the sisters went on to become a sensation of the Canadian 
depression-era.  
8
 The September 1954 membership list is appended to the secretary’s report and published in 
American Journal of Human Genetics, 7 (1955), pp. 466-95.  
9
 A significant proportion of the material that follows in this section comes from interviews with 
people who were involved in the process of establishing the Canadian College of Medical 
Geneticists. I am indebted to Dr. Hubert C. Soltan for his review of what I have written 
elsewhere on this subject. I am also indebted to Peggy Souter and Jean McQulliam of the 
Membership Section of the Royal College of Physicians and Surgeons (Canada) for their 
assistance. 
10
 A final organization, the Genetic Nurses and Social Worker’s Association, was also created 
that year for allied health personnel working in the field. The four organizations eventually came 
together under an umbrella organization known as the British Society for Human Genetics, 
formed in 1996. 
11
 See, for example, Medical Research Council/Department of Health and Social Security Joint 
Working Group on Genetics (1980), British Paediatric Association (1979), Medical Research 
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Council Sub-Committee on Genetics (1978), Department of Health and Social Security 
(1977:22-7; 1976a, 1976b, 1976c). 
12
 The reader can make a comparison here with Peter Keating and Alberto Cambrosio’s model of 
“biomedical platforms” which suggests “a distinctive place for technology and its development 
other than that of a simple tool for the furtherance of intellectual goals” (2003: 2). Keating and 
Alberto Cambrosio have described biomedical platforms as “material and discursive 
arrangements that act as the bench upon which conventions concerning the biological or normal 
are connected with conventions concerning the medical or pathological” (2003:4). What emerges 
from their model is a useful and flexible way to conceptualize medical specialization and the 
ability to transform the organization and structures of contemporary biomedical institutions and 
practices at both the national and local levels. Specialisms appear in this model in terms of 
overlapping organizing principles. They are not so much the result of turf wars among competing 
segments of service providers but, rather, products of mutual dependency and networked 
innovation (2003: 19-20; cf. Powell, Koput, and Smith-Doerr, and 1996; Scarbrough and Swan, 
2005; Shinn, 2005). 
